bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Feb. 4, 2023
Abstract
Mesenchymal
stromal
cells
(MSCs)
have
shown
promise
in
regenerative
medicine
applications
due
part
to
their
ability
modulate
immune
cells.
However,
MSCs
demonstrate
significant
functional
heterogeneity
terms
of
immunomodulatory
function
because
differences
MSC
donor/tissue
source,
as
well
non-standardized
manufacturing
approaches.
As
metabolism
plays
a
critical
role
expand
therapeutic
numbers
ex
vivo
,
we
comprehensively
profiled
intracellular
and
extracellular
metabolites
throughout
the
expansion
process
identify
predictors
(T
cell
modulation
indoleamine-2,3-dehydrogenase
(IDO)
activity).
Here,
media
non-destructive
manner
through
daily
sampling
nuclear
magnetic
resonance
(NMR),
at
end
using
mass
spectrometry
(MS).
Using
robust
consensus
machine
learning
approach,
were
able
panels
predictive
for
10
independent
lines.
This
approach
consisted
identifying
2
or
more
models
then
building
based
on
these
metabolite
panels.
Consensus
with
high
value
included
multiple
lipid
classes
(such
phosphatidylcholines,
phosphatidylethanolamines,
sphingomyelins)
while
proline,
phenylalanine,
pyruvate.
Pathway
enrichment
identified
metabolic
pathways
significantly
associated
such
sphingolipid
signaling
metabolism,
arginine
proline
autophagy.
Overall,
this
work
establishes
generalizable
framework
that
predict
function,
guiding
future
efforts
identification
potency
lines
engineering.
Best Practice & Research Clinical Rheumatology,
Journal Year:
2023,
Volume and Issue:
37(2), P. 101852 - 101852
Published: June 1, 2023
Osteoarthritis
(OA)
is
the
most
common
form
of
arthritis
globally
and
a
major
cause
pain,
physical
disability,
loss
economic
productivity,
with
currently
no
causal
treatment
available.
This
review
article
focuses
on
current
research
OA
biomarkers
potential
for
using
in
future
clinical
practice
trials
investigational
drugs.
We
discuss
how
biomarkers,
specifically
soluble
ones,
have
long
path
to
go
before
reaching
standards
care.
also
can
help
phenotyping
subtyping
achieve
enhanced
stratification
move
toward
better-designed
trials.
describe
be
used
molecular
endotyping
determining
outcomes
cell-based
therapies.
Biomarkers
developed
as
surrogate
end
points
private-public
consortia
biotechnology
pharmaceutical
industries
develop
more
effective
targeted
personalized
treatments
enhance
care
patients
OA.
Science Translational Medicine,
Journal Year:
2023,
Volume and Issue:
15(688)
Published: March 22, 2023
Multipotent
stromal
cells
are
considered
attractive
sources
for
cell
therapy
and
tissue
engineering.
Despite
numerous
experimental
clinical
studies,
broad
application
of
therapeutics
is
not
yet
emerging.
A
major
challenge
the
functional
diversity
available
sources.
Here,
we
investigated
regenerative
potential
clinically
relevant
human
from
bone
marrow
(BMSCs),
white
adipose
tissue,
umbilical
cord
compared
with
mature
chondrocytes
skin
fibroblasts
in
vitro
vivo.
Although
all
types
could
express
transcription
factors
related
to
endochondral
ossification,
only
BMSCs
formed
cartilage
discs
that
fully
regenerated
critical-size
femoral
defects
after
transplantation
into
mice.
We
identified
type–specific
epigenetic
landscapes
as
underlying
molecular
mechanism
controlling
transcriptional
differentiation
networks.
Binding
sites
commonly
expressed
enhancer
promoter
regions
ossification-related
genes,
including
Runt
bZIP
families,
were
accessible
but
extraskeletal
cells.
This
suggests
an
epigenetically
predetermined
depending
on
origin
allows
common
trigger
distinct
organ-specific
programs,
facilitating
forward
selection
regeneration-competent
Last,
demonstrate
viable
initiated
defect
healing
through
secretion
osteopontin
contributed
transient
mineralized
hard
callus
formation
immunodeficient
mice,
which
was
eventually
replaced
by
murine
recipient
during
final
remodeling.
Arthritis Research & Therapy,
Journal Year:
2023,
Volume and Issue:
25(1)
Published: Jan. 10, 2023
Platelet-rich
plasma
(PRP)
therapy
is
increasingly
popular
to
treat
musculoskeletal
diseases,
including
tendinopathies
and
osteoarthritis
(OA).
To
date,
it
remains
unclear
which
extent
PRP
compositions
are
determined
by
the
immune
cell
cytokine
profile
of
individuals
or
preparation
method.
investigate
this,
we
compared
leukocyte
distributions
different
products
donor
blood
samples
assessed
effect
pro-inflammatory
cytokines
on
chondrocytes.
Frontiers in Cell and Developmental Biology,
Journal Year:
2025,
Volume and Issue:
13
Published: Jan. 27, 2025
Background
A
significant
number
of
platelet
concentrates
(PCs)
is
discarded
daily
in
blood
banks
due
to
limited
shelf
life.
Human
lysate
(HPL),
derived
from
expired
PCs,
has
gained
attention
as
an
ethical
and
sustainable
cell
culture
media
supplement
biomedical
research
therapy
production.
However,
HPL
subject
decisive
disadvantages
such
batch
differences
lack
storage
stability.
To
overcome
these
limitations
enhance
the
applicability
HPL,
we
developed
manufacturing
protocol
including
a
lyophilization
process.
The
aim
this
study
was
investigate
influence
on
parameters
quality
control,
growth
factor
concentrations
human
mesenchymal
stromal
cells
(hMSCs).
Methods
We
performed
paired
comparison
six
batches
lyophilized
(L-HPL)
regarding
pH,
total
protein,
osmolality,
sodium,
potassium
chloride
concentration.
Concentrations
11
factors
cytokines
were
compared
between
L-HPL.
Additionally,
determined
yield,
proliferation
capacity,
viability
trilineage
differentiation
potential
hMSCs
following
expansion
HPL-
L-HPL-supplemented
media.
Results
Quantification
revealed
non-altered
osmolality
slightly
lower
sodium
L-HPL
HPL.
Growth
cytokine
did
not
differ
Cell
division
cycles
cultured
either
or
L-HPL-containing
comparable.
Cells
differentiated
medium
containing
showed
higher
capacity
for
osteogenic
differentiation,
while
adipogenic
chondrogenic
potentials
remained
unchanged.
Conclusion
successfully
method
produce
well-applicable
with
reveal
any
relevant
control
routine
testing,
hMSC
functionality,
demonstrating
suitability
supplement.
These
results
emphasize
alternative
animal-derived
serum
products
drug
development.
Journal of Chemical Information and Modeling,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 5, 2025
Specificity,
sensitivity,
and
high
metabolite
coverage
make
mass
spectrometry
(MS)
one
of
the
most
valuable
tools
in
metabolomics
lipidomics.
However,
translation
MS
methods
to
multiyear
studies
conducted
across
multiple
batches
is
limited
by
variability
electrospray
ionization
response,
making
batch-to-batch
comparisons
challenging.
This
limitation
creates
an
artificial
divide
between
nontargeted
discovery
work
that
broad
scope
but
terms
absolute
quantitation
ability
targeted
highly
accurate
due
need
for
matched
isotopically
labeled
standards.
These
issues
are
often
observed
stem
cell
using
metabolomic
lipidomic
approaches,
where
patient
recruitment
can
be
a
years-long
process
samples
become
available
discrete
every
few
months.
To
bridge
this
gap,
we
developed
machine
learning
model
predicts
sensitivity
lipid
classes
have
shown
correlation
with
potency.
Molecular
descriptors
derived
from
these
lipids'
chemical
structures
used
as
input
predict
enabling
moderate
accuracy
(semiquantitation).
Model
performance
was
evaluated
via
internal
external
validation
cultured
cells
various
donors,
achieving
global
percent
errors
40%
20%
positive
negative
ion
modes,
respectively.
Although
typically
insufficient
traditional
lipidomics
experiments,
it
sufficient
semiquantitative
estimation
marker
concentrations
without
specific
standards
many
times
unavailable.
Furthermore,
precision
model-predicted
16.9%
mode
7.5%
mode,
indicating
promise
data
harmonization
batches.
The
set
molecular
models
described
here
able
yield
higher
than
those
previously
published
literature,
showing
toward
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
13
Published: Feb. 12, 2025
Over
the
past
decade,
development
of
nanomaterials
(NMs)
has
surged,
highlighting
their
potential
benefits
across
multiple
industries.
However,
concerns
regarding
human
and
environmental
exposure
remain
significant.
Traditional
in
vivo
models
for
safety
assessments
are
increasingly
viewed
as
unfeasible
unethical
due
to
diverse
forms
biological
effects
NMs.
This
prompted
design
Novel
Approach
Methods
(NAMs)
streamline
risk
assessment
predict
hazards
without
relying
on
animal
testing.
A
critical
aspect
advancing
NAMs
is
urgent
need
replace
animal-derived
products
assay
protocols.
Incorporating
or
synthetic
alternatives
can
significantly
reduce
ethical
burden
use
while
enhancing
relevance
toxicity
study
evaluates
impact
removing
from
standard
acellular
vitro
assays
recommended
a
published
Integrated
Approaches
Testing
Assessment
(IATA)
inhaled
We
specifically
assessed
replacing
fetal
bovine
serum
with
platelet
lysate
reactivity
tests
testing
using
panel
well-characterized
Significant
differences
NM
dramatic
changes
A549
cell
growth
rates
responses
NMs
were
observed
under
different
media
conditions.
Our
findings
demonstrate
that
variations
experimental
setup
fundamentally
hazard
assessment,
influencing
interpretation
results
within
specific
tiered
strategies.
Further
investigation
needed
support
shift
toward
more
does
not
rely
materials.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 12, 2025
AbstractBackground:
Genomic
editing
technologies
provide
rich
opportunities
to
approach
inherited
human
diseases,
but
gene
delivery
strategies
are
still
challenging.
While
engineered
induced
pluripotent
stem
cells
or
adeno-associated
viral
vectors
may
be
associated
with
severe
adverse
effects,
mesenchymal
stromal
(MSC)
have
abundantly
been
used
for
various
cell
therapeutic
and
proven
safe
in
a
large
number
of
clinical
trials.
MSC
can
expanded
ex
vivoon
scale,
genetic
engineering
these
somatic
therefore
offer
an
alternative
mode
delivery.
Methods:
We
applied
the
guide
RNA-directed
CRISPR/Cas9
synergistic
activation
mediator
(SAM)
technology
immortalized
(iMSC)
primary
(pMSC)
order
activate
expression
CEBPACIITA.
Results:
After
meticulous
protocol
optimization,
both
genes
were
successfully
MSC.
For
CIITA
induction,
we
confirmed
downstream
target
HLA-DR
on
mRNA
protein
level.
Unlike
adipogenic,
chondrogenic
osteogenic
genes,
which
naturally
upon
in
vitro
differentiation,
HLA
class
II
molecules
not
constitutively
expressed
Lentiviral
transposon-based
applied,
only
lentiviral
transduction
SAM
sequences,
CEBPA,CIITA,
HLA-DR
HLA-DR
achieved
pMSC.
Conclusion:
guided
system
was
capable
induce
transcriptionally
silent
iMSC
The
resulting
genetically
suitable
promising
cell-based
strategies.
Frontiers in Cell and Developmental Biology,
Journal Year:
2023,
Volume and Issue:
11
Published: Feb. 21, 2023
Patients
suffering
from
musculoskeletal
diseases
must
cope
with
a
diminished
quality
of
life
and
an
increased
burden
on
medical
expenses.
The
interaction
immune
cells
mesenchymal
stromal
during
bone
regeneration
is
one
the
key
requirements
for
restoration
skeletal
integrity.
While
osteo-chondral
lineage
support
regeneration,
excessive
accumulation
adipogenic
thought
to
promote
low-grade
inflammation
impair
regeneration.
Increasing
evidence
indicates
that
pro-inflammatory
signaling
adipocytes
responsible
various
chronic
diseases.
This
review
aims
summarize
features
marrow
by
phenotype,
function,
secretory
features,
metabolic
properties
their
impact
formation.
In
detail,
master
regulator
adipogenesis
prominent
diabetes
drug
target,
peroxisome
proliferator-activated
receptor
γ
(PPARG),
will
be
debated
as
potential
therapeutic
approach
enhance
We
explore
possibilities
using
clinically
established
PPARG
agonists,
thiazolidinediones
(TZDs),
treatment
strategy
guide
induction
pro-regenerative,
metabolically
active
adipose
tissue.
this
induced
tissue
type
providing
necessary
metabolites
sustain
osteogenic-as
well
beneficial
fracture
healing
highlighted.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 11, 2023
Heterotopic
ossification
is
a
disorder
caused
by
abnormal
mineralization
of
soft
tissues
in
which
signaling
pathways
such
as
BMP,
TGFβ
and
WNT
are
known
key
players
driving
ectopic
bone
formation.
Identifying
novel
genes
related
to
the
process
important
steps
for
future
gene
therapy
disorders.
In
this
study,
we
detect
an
inter-chromosomal
insertional
duplication
female
proband
disrupting
topologically
associating
domain
causing
ultra-rare
progressive
form
heterotopic
ossification.
This
structural
variant
lead
enhancer
hijacking
misexpression
ARHGAP36
fibroblasts,
validated
here
orthogonal
vitro
studies.
addition,
overexpression
inhibits
TGFβ,
activates
hedgehog
genes/proteins
extracellular
matrix
production.
Our
work
on
genetic
cause
case
has
revealed
that
plays
role
formation
metabolism,
outlining
first
details
contributing
bone-formation
-disease.